Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$BCYC Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.15 up 82.35% YoY • Reported revenue of $34.06M up 190.37% YoY • Bicycle Therapeutics reported cash and cash equivalents of $469.9M as of September 30, 2026, with expected cash runway into 2030, as stated in quarterly results.
1

Price since post

Full Details

Advertisement|Remove ads.